Fund shareholders of Genscript Biotech Corp
ISIN KYG3825B1059 · Hong Kong SAR China · LEI 529900YIYUOJOXSAE372
- Fund shareholders
- 102
- Of which ETFs
- 41 61 other funds
- Value held
- ≈ 226.8M $ 220.6M $ · 59.2M SEK
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Franklin FTSE Asia ex Japan ETF Franklin Templeton ETF Trust | 5,000 | 7.8K $ | 0.02 % | as of Jun 30, 2026 ↗ |
| GodFond Sverige & Världen Storebrand Asset Management AS | 2,000 | 26.6K SEK | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Global X Genomics & Biotechnology ETF GLOBAL X FUNDS | 2.00 % | as of May 31, 2026 ↗ |
| T. Rowe Price China Evolution Equity Fund T. ROWE PRICE INTERNATIONAL FUNDS, INC. | 1.63 % | as of Jul 31, 2026 ↗ |
| KraneShares MSCI All China Health Care Index ETF Krane Shares Trust | 1.11 % | as of Jun 30, 2026 ↗ |
| Matthews China Fund Matthews International Funds | 0.53 % | as of Jun 30, 2026 ↗ |
| Matthews China Active ETF Matthews International Funds | 0.51 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price New Asia Fund T. ROWE PRICE INTERNATIONAL FUNDS, INC. | 0.48 % | as of Jul 31, 2026 ↗ |
| Avantis Emerging Markets Small Cap Equity ETF American Century ETF Trust | 0.18 % | as of May 31, 2026 ↗ |
| THE EMERGING MARKETS SMALL CAP SERIES DFA INVESTMENT TRUST CO | 0.15 % | as of Jul 31, 2026 ↗ |
| WisdomTree China ex-State-Owned Enterprises Fund WisdomTree Trust | 0.14 % | as of Jun 30, 2026 ↗ |
| iShares ESG Aware MSCI EM ETF iShares, Inc. | 0.10 % | as of May 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 89 | +8 | 104,784,800 | +13.9 % |
| 2026Q2 | 81 | 0 | 91,960,606 | +3.5 % |
| 2026Q1 | 81 | +2 | 88,832,665 | +1.9 % |
| 2025Q4 | 79 | +3 | 87,135,753 | +9.4 % |
| 2025Q3 | 76 | +3 | 79,660,532 | +6.6 % |
| 2025Q2 | 73 | +5 | 74,725,386 | +1.9 % |
| 2025Q1 | 68 | -4 | 73,316,394 | -7.2 % |
| 2024Q4 | 72 | -4 | 78,972,239 | +3.2 % |
| 2024Q3 | 76 | -2 | 76,551,625 | +10.5 % |
| 2024Q2 | 78 | +7 | 69,252,866 | +69.1 % |
| 2024Q1 | 71 | -8 | 40,944,925 | -43.1 % |
| 2023Q4 | 79 | 72,003,019 |
Cite this page
Titelia. "Fund shareholders of Genscript Biotech Corp". https://titelia.com/en/stocks/genscript-biotech-corp-KYG3825B1059